Marijuana Company Of America Inc (OTCMKTS:MCOA) is a stock that has exploded higher in recent days on the Company’s prelaunch announcement for HempSMART Brain (a Hemp Derived CBD Product to Support Brain Function).
The announcement comes amid the new Marijuana Mania craze gripping the markets into the November voting measures. And it has unleashed a massive bid for shares of MCOA. The stock was up another 45% today, after making a 100% advance during the prior two days. Volume has been dramatic, with a jump in recent days just shy of 660% above the average volume levels in play in this stock over the longer term.
Marijuana Company Of America Inc (OTCMKTS:MCOA) trumpets itself as a company that operates as a marijuana marketing and distribution company. It intends to distribute a range of marijuana, CBD, and related products in the United States and internationally.
The company was formerly known as Converge Global, Inc. and changed its name to Marijuana Company of America, Inc. in December 2015. Marijuana Company of America, Inc. was founded in 1985 and is headquartered in Bonsall, California.
According to the Company’s press materials, “MCOA plans to distribute marijuana and products related to marijuana as well as CBD and hemp, using a variety of marketing approaches to distribute on a global basis.”
Find out when $MCOA reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Traders should first understand that the hempSMART brand represents MCOA’s non-THC, hemp derived, product line. All HempSmart products are formulated with a cannabinoid base that is derived from hemp and has less than a .3% THC content
With the recent news of their prelaunch of the hempSMART Brain product, the Company is making a major statement about its commitment to address the increase in neurologic and neurodegenerative challenges that have prompted a surge in scientific research on prevention and/or reversal of brain and nervous system pathology.
“We are very excited to announce the hempSMART Brain prelaunch as we prepare to begin shipping orders in the coming weeks. A lot of time and energy went into developing this product and we are looking forward to getting it into the hands of our customers,” said CEO, Donald Steinberg.
Moreover, a variety of natural products have been shown, in clinical trials, to improve neurological and cognitive function and there has been a surge of products being marketed to improve brain function. While the efficacy of some of these blends has been impressive, many utilize trace amounts of therapeutic ingredients, inadequate for any clinical effect.
The Company has the following marketing strategy message to pursue market share:
“HempSMART Brain is unique in that it utilizes a synergistic blend of natural neuroprotective and neuroregenerative compounds, all in clinically researched and verified therapeutic amounts. The Core Ingredients for this product are CBD, Astaxanthin, Phosphoryl Choline and Phosphatidyl Serine. Together, these ingredients promote and support brain function and neurogenesis. Additional natural compounds compliment the synergistic effects of the core ingredients.
HempSMART exemplifies the practical application of cutting edge research and premium botanical ingredients, in therapeutic amounts. HempSMART Brain is the first of its kind. The synergistic blend of clinically verified natural brain support, with water soluble CBD, crosses the blood-brain barrier and offers brain support and protection not previously available in the marketplace.”
So far, that message is being mobilized through invitations to direct sales leaders and a referral system. The response will determine volume in terms of production spend.
Our sense is, this is interesting given the footprint expansion almost certainly on the way in November, when 9 states go to their respective ballot boxes and contemplate further legalization of marijuana.
At this time, carrying a capital value in the market of $15.9M, MCOA has minimal cash on the books, which stands against an appreciable load ($589.68k) of total accumulated debt. That’s the main drawback here with this story. How much of a ramp in production can you achieve without resources? They can ramp the debt from here, and maybe they have. But we need to see organic growth to get excited about too much of an extension in a stock that has already run 200% in the past 3 days. That said, momentum in the space is crazy town and we may get new info that supports a major non-linear shift in share movement. We will update as soon as we see more info on this very exciting play. For continuing coverage on $MCOA and our other fast moving picks, sign up for our free newsletter today and get our next hot stock pick!